Knockdown of RCAS1 expression by RNA interference recovers T cell growth and proliferation

Yuan Han1, Wenxin Qin, Gang Huang

  • 1Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, No. 145 Middle Shandong Road, Shanghai 200001, People's Republic of China.

Cancer Letters
|September 11, 2007
PubMed

Insights

Receptor binding cancer antigen expressed on SiSo cells (RCAS1) promotes tumor immune escape. Suppressing RCAS1 expression via RNA interference restores T cell proliferation and function, offering a potential therapeutic strategy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Receptor binding cancer antigen expressed on SiSo cells (RCAS1) is a tumor-associated antigen implicated in tumor immune escape.
  • RCAS1 expression is observed in various malignant tissues, suggesting its role in cancer progression.

Purpose of the Study:

  • To investigate the effect of RCAS1 knockdown on T cell function.
  • To explore the potential of targeting RCAS1 for cancer immunotherapy.

Main Methods:

  • Designed and utilized small hairpin RNA (shRNA) to effectively knockdown RCAS1 expression in MCF-7 cells.
  • Assessed T cell growth rate, apoptosis ratio, Caspase-3 activity, and IFN-gamma secretion following RCAS1 modulation.

Main Results:

  • Knockdown of RCAS1 expression using shRNA successfully reduced RCAS1 levels in MCF-7 cells.
  • Exposure to RCAS1 protein led to decreased T cell proliferation, increased apoptosis, elevated Caspase-3 activity, and reduced IFN-gamma secretion.
  • Suppression of RCAS1 expression reversed these effects, restoring T cell proliferation, reducing apoptosis, and partially restoring IFN-gamma secretion.

Conclusions:

  • RCAS1 plays a significant role in suppressing T cell activity and promoting immune evasion in cancer.
  • Targeting RCAS1 expression through RNA interference can restore T cell-mediated immune responses.
  • Modulating RCAS1 presents a promising therapeutic avenue for enhancing anti-tumor immunity.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...